1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Disease Exacerbation in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Han, C; Li, L; Li, M; Liu, Y; Mao, Y; Song, S; Wang, Z; Xu, B; Yu, G; Zhou, L | 1 |
| Cong, Q; Gao, T; Jiang, W; Sun, M; Wang, Y; Xu, C; Yao, L; Yu, Y | 1 |
| Lordan, R; Tsoupras, A; Zabetakis, I | 1 |
| Gao, L; He, M; Ni, X; Sun, Y; Tang, G; Wang, L; Xu, B; Yu, Y | 1 |
| Au, C; Dukhinova, M; Lau, AY; Ponomarev, ED; Starossom, SC; Veremeyko, T; Weiner, HL; Yung, AW | 1 |
| Demopoulos, C; Giaginis, C; Gribilas, G; Karantonis, HC; Kouraklis, G; Spiliopoulou, C; Stamoulis, I; Theocharis, SE | 1 |
| Bar-Eli, M; Melnikova, VO | 1 |
| Bambach, I; Huettner, B; Koefeler, H; Mayer, G; Schön, MP; Singh, TP; Wallbrecht, K; Wolf, P | 1 |
| Bachi, AL; Dos Santos, LC; Jancar, S; Jasiulionis, MG; Nonogaki, S | 1 |
| Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Nomikos, T | 1 |
| Kingsnorth, AN; Makhija, R | 1 |
| Slomiany, A; Slomiany, BL | 1 |
| Croxtall, JD; Gilroy, DW; Newson, J; Sawmynaden, P; Willoughby, DA | 1 |
| Angeli, V; Fisher, EA; Liu, J; Llodrá, J; Randolph, GJ; Trogan, E | 1 |
| Dong, Q; Kurek, C; Patel, MI | 1 |
| Garito, ML; McManus, LM; Prihoda, TJ | 1 |
| Markey, SP; Nishida, K | 1 |
| Camici, M | 1 |
| Dixon, SJ; Hafezi, M; Sandhu, HS; Sims, SM; Wiebe, SH | 1 |
| Camici, M; Carpi, A; Sagripanti, A | 1 |
| Kitsiouli, EI; Lekka, ME; Nakos, G; Tsangaris, I | 1 |
| Johnson, CD | 1 |
| Arese, M; Bargnani, C; Bussolino, F; Callea, L; Orlandini, A; Priori, A | 1 |
| Dzakpasu, P; Kornecki, E; Leblanc, P; Piecuch, S; Rabinowitz, SS; Valencia, G | 1 |
8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease Exacerbation
| Article | Year |
|---|---|
The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.
Topics: Diet; Diet, Mediterranean; Disease Progression; Humans; Neoplasms; Platelet Activating Factor | 2019 |
Inflammation and melanoma metastasis.
Topics: Chemokines; Disease Progression; Humans; Immune System; Inflammation; Interleukins; Keratinocytes; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Platelet Activating Factor; Platelet Activation; Receptor, PAR-1; Stromal Cells | 2009 |
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Disease Progression; Drug Design; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Ischemia; Platelet Activating Factor | 2013 |
Cytokine storm in acute pancreatitis.
Topics: Acute Disease; Animals; Antibody Formation; Apoptosis; Disease Progression; Humans; Immunity, Cellular; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Pancreatitis; Platelet Activating Factor; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2002 |
The arachidonic acid pathway and its role in prostate cancer development and progression.
Topics: Animals; Annexins; Arachidonic Acid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Disease Progression; Group II Phospholipases A2; Humans; Lipoxygenase; Male; Oxygenases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms | 2008 |
[Progression of renal insufficiency and platelet activating factor (PAF)].
Topics: Disease Progression; Glomerular Mesangium; Humans; Kidney; Platelet Activating Factor; Renal Insufficiency | 1996 |
Osteoclast activation in inflammatory periodontal diseases.
Topics: Alveolar Bone Loss; Animals; Cytokines; Disease Progression; Humans; Inflammation Mediators; Interferon-gamma; Interleukins; Lipopolysaccharides; Osteoclasts; Periodontitis; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1996 |
Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.
Topics: Acute Disease; Animals; Disease Progression; Humans; Pancreatitis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prognosis; Rats; Sensitivity and Specificity; Treatment Outcome | 1999 |
16 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease Exacerbation
| Article | Year |
|---|---|
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indoles; Male; Mice; Paclitaxel; PC-3 Cells; Platelet Activating Factor; Prostatic Neoplasms, Castration-Resistant; Up-Regulation | 2020 |
Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Topics: Animals; Azepines; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Disease Progression; Female; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles; Tumor Microenvironment | 2018 |
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Androgen Receptor Antagonists; Androgens; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclofenil; Dihydrotestosterone; Disease Progression; Estradiol; Hormone Antagonists; Humans; Imidazoles; Indoles; Male; Mifepristone; Platelet Activating Factor; Prostatic Neoplasms; Protein Kinase Inhibitors; RNA Interference; RNA, Small Interfering; Wnt Proteins | 2013 |
Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation.
Topics: Adult; Animals; Blood Platelets; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coculture Techniques; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Humans; Interferon-gamma; Interleukin-17; Male; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Scanning; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Platelet Factor 4; Serotonin | 2015 |
Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Progression; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Platelet Activating Factor; Rats; Rats, Wistar; Severity of Illness Index; Thioacetamide | 2010 |
Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.
Topics: Animals; Cytokines; Dihydropyridines; Disease Progression; Down-Regulation; Humans; Mice; Mice, Transgenic; Phenotype; Platelet Activating Factor; Platelet Membrane Glycoproteins; Psoriasis; PUVA Therapy; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Skin; STAT3 Transcription Factor; Th17 Cells; Transforming Growth Factor beta1; Up-Regulation | 2011 |
Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor.
Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Melanoma; Mice; Mice, Inbred C57BL; Phagocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2012 |
Biphasic role of platelet-activating factor in oral mucosal ulcer healing.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Blotting, Western; Cyclooxygenase 2; Disease Progression; Ginkgolides; Isoenzymes; Lactones; Mouth Mucosa; Mucous Membrane; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Ulcer | 2003 |
A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation.
Topics: Acute Disease; Animals; Arachidonic Acid; Carrageenan; Cells, Cultured; Convalescence; Corticosterone; Cyclooxygenase 2; Disease Progression; Enzyme Induction; Epithelial Cells; Fibroblasts; Group II Phospholipases A2; Group IV Phospholipases A2; Group V Phospholipases A2; Group VI Phospholipases A2; Interleukin-1; Isoenzymes; Leukotriene B4; Lipoxins; Macrophages; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 2004 |
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.
Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Cell Movement; Disease Progression; Endothelium, Vascular; Female; Kinetics; Lipids; Lysophospholipids; Male; Mice; Mice, Knockout; Monocytes; Platelet Activating Factor; Transplantation, Homologous | 2004 |
Salivary PAF levels correlate with the severity of periodontal inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Chromatography, Thin Layer; Disease Progression; Dose-Response Relationship, Immunologic; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Neutrophils; Periodontal Index; Periodontal Pocket; Periodontitis; Platelet Activating Factor; Saliva | 1995 |
Platelet-activating factor in brain regions after transient ischemia in gerbils.
Topics: Animals; Brain Chemistry; Cerebellum; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Disease Progression; Female; Gas Chromatography-Mass Spectrometry; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Platelet Activating Factor; Reperfusion; Thalamus | 1996 |
[Platelet activating factor (PAF) and kidney failure progression].
Topics: Blood Coagulation; Disease Progression; Humans; Platelet Activating Factor; Renal Insufficiency | 1997 |
Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.
Topics: Adolescent; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; Case-Control Studies; Disease Progression; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Platelet Activating Factor; Prognosis; Prospective Studies; Proteins; Pulmonary Surfactants; Reproducibility of Results; Respiratory Distress Syndrome; Time Factors | 1998 |
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood-Brain Barrier; Capillaries; Child; Disease Progression; Female; Gadolinium; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence | 1999 |
Platelet-activating factor in infants at risk for necrotizing enterocolitis.
Topics: Case-Control Studies; Disease Progression; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Platelet Activating Factor; Predictive Value of Tests; Risk Factors; Severity of Illness Index | 2001 |